Investment

Details

Screening Program
  • RFP Year
    2020
  • Awarded Amount
    $118,300
  • Disease
    Tuberculosis
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Daiichi Sankyo RD Novare Co., Ltd., The Global Alliance for TB Drug Development